EDGAR Filing Documents for 0001539497-21-000910

Form S-1 - General form for registration of securities under the Securities Act of 1933:

SEC Accession No. 0001539497-21-000910

Filing Date

2021-06-24

Accepted

2021-06-24 08:19:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-1	n2583-x5_s1.htm	S-1	2913803
2	LICENSE AGREEMENT BETWEEN BIOXYTRAN, INC. AND PHARMALECTIN, INC. DATED MAY 5, 20	exh10-59.htm	EX-10.59	61598
3	LICENSE AGREEMENT BETWEEN PHARMALECTIN, INC. AND NDPD PHARMA, INC. DATED MAY 2,	exh10-60.htm	EX-10.60	59997
4	2021 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN, ADOPTED BY THE BOARD OF DIREC	exh10-61.htm	EX-10.61	134594
5	2017 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (SUBSIDIARY), ADOPTED BY THE B	exh10-62.htm	EX-10.62	134992
6	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	exh23-1.htm	EX-23.1	2792
	Complete submission text file	0001539497-21-000910.txt		9563322

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE FILE	bixt-20210331.xml	EX-101.INS	1933461
8	XBRL SCHEMA FILE	bixt-20210331.xsd	EX-101.SCH	57822
9	XBRL CALCULATION FILE	bixt-20210331_cal.xml	EX-101.CAL	47278
10	XBRL DEFINITION FILE	bixt-20210331_def.xml	EX-101.DEF	257043
11	XBRL LABEL FILE	bixt-20210331_lab.xml	EX-101.LAB	431045
12	XBRL PRESENTATION FILE	bixt-20210331_pre.xml	EX-101.PRE	343646

Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464

Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199